Cerebellar ataxia, neuropathy, vestibular areflexia syndrome due to RFC1 repeat expansion.


Journal

Brain : a journal of neurology
ISSN: 1460-2156
Titre abrégé: Brain
Pays: England
ID NLM: 0372537

Informations de publication

Date de publication:
01 02 2020
Historique:
received: 05 08 2019
revised: 21 11 2019
accepted: 27 11 2019
entrez: 11 2 2020
pubmed: 11 2 2020
medline: 7 7 2020
Statut: ppublish

Résumé

Ataxia, causing imbalance, dizziness and falls, is a leading cause of neurological disability. We have recently identified a biallelic intronic AAGGG repeat expansion in replication factor complex subunit 1 (RFC1) as the cause of cerebellar ataxia, neuropathy, vestibular areflexia syndrome (CANVAS) and a major cause of late onset ataxia. Here we describe the full spectrum of the disease phenotype in our first 100 genetically confirmed carriers of biallelic repeat expansions in RFC1 and identify the sensory neuropathy as a common feature in all cases to date. All patients were Caucasian and half were sporadic. Patients typically reported progressive unsteadiness starting in the sixth decade. A dry spasmodic cough was also frequently associated and often preceded by decades the onset of walking difficulty. Sensory symptoms, oscillopsia, dysautonomia and dysarthria were also variably associated. The disease seems to follow a pattern of spatial progression from the early involvement of sensory neurons, to the later appearance of vestibular and cerebellar dysfunction. Half of the patients needed walking aids after 10 years of disease duration and a quarter were wheelchair dependent after 15 years. Overall, two-thirds of cases had full CANVAS. Sensory neuropathy was the only manifestation in 15 patients. Sixteen patients additionally showed cerebellar involvement, and six showed vestibular involvement. The disease is very likely to be underdiagnosed. Repeat expansion in RFC1 should be considered in all cases of sensory ataxic neuropathy, particularly, but not only, if cerebellar dysfunction, vestibular involvement and cough coexist.

Identifiants

pubmed: 32040566
pii: 5733001
doi: 10.1093/brain/awz418
pmc: PMC7009469
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

480-490

Subventions

Organisme : Wellcome Trust
ID : 206675/Z/17/Z
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/N025431/1
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/N010035/1
Pays : United Kingdom
Organisme : Medical Research Council
ID : G1000848
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/N025431/2
Pays : United Kingdom
Organisme : European Research Council
ID : 309548
Pays : International
Organisme : Medical Research Council
ID : MR/S01165X/1
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/T001712/1
Pays : United Kingdom
Organisme : Wellcome Trust
ID : 203148/Z/16/Z
Pays : United Kingdom
Organisme : Wellcome Trust
ID : 212219/Z/18/Z
Pays : United Kingdom
Organisme : Medical Research Council
ID : G0601943
Pays : United Kingdom

Commentaires et corrections

Type : CommentIn
Type : CommentIn

Informations de copyright

© The Author(s) (2020). Published by Oxford University Press on behalf of the Guarantors of Brain.

Références

J Neurol. 2018 Jun;265(6):1454-1462
pubmed: 29696497
Am J Hum Genet. 2019 Jul 3;105(1):151-165
pubmed: 31230722
Laryngoscope. 2012 Aug;122(8):1858-61
pubmed: 22645067
Brain. 2004 Feb;127(Pt 2):280-93
pubmed: 14607788
Eye (Lond). 2015 Feb;29(2):163-70
pubmed: 25412719
Auris Nasus Larynx. 2018 Aug;45(4):866-870
pubmed: 29089158
J Neurol Sci. 2018 Apr 15;387:75-79
pubmed: 29571876
Neurology. 2014 Apr 22;82(16):1410-5
pubmed: 24682971
Brain. 1991 Feb;114 ( Pt 1A):1-11
pubmed: 1998877
Acta Neuropathol. 1969;13(3):197-216
pubmed: 5805973
JAMA. 2019 Jun 4;321(21):2131-2133
pubmed: 31162561
Semin Neurol. 1987 Mar;7(1):58-66
pubmed: 3332448
Neurol Clin Pract. 2016 Feb;6(1):61-68
pubmed: 26918204
J Neurol. 2016 Feb;263(2):245-249
pubmed: 26566912
Brain. 2014 Oct;137(Pt 10):2649-56
pubmed: 25070514
Diabetes Care. 1985 Sep-Oct;8(5):491-8
pubmed: 4053936
J Vestib Res. 2017;27(4):177-189
pubmed: 29081426
Ann N Y Acad Sci. 2011 Sep;1233:139-47
pubmed: 21950986
Nat Genet. 2019 Apr;51(4):649-658
pubmed: 30926972
Brain. 2009 Jul;132(Pt 7):1723-33
pubmed: 19506068
Eur J Neurol. 2018 Apr;25(4):659-665
pubmed: 29316033
PLoS One. 2013 May 09;8(5):e61862
pubmed: 23671577
Ann Neurol. 2000 Jan;47(1):104-9
pubmed: 10632108
Brain. 1999 Jul;122 ( Pt 7):1293-303
pubmed: 10388795
Brain. 1985 Dec;108 ( Pt 4):897-924
pubmed: 4075078

Auteurs

Andrea Cortese (A)

Department of Neuromuscular Disease, UCL Queen Square Institute of Neurology and The National Hospital for Neurology, London, UK.
Department of Brain and Behavioral Sciences, University of Pavia, Pavia, Italy.

Stefano Tozza (S)

Department of Neuromuscular Disease, UCL Queen Square Institute of Neurology and The National Hospital for Neurology, London, UK.
Department of Neuroscience, Reproductive Sciences and Odontostomatology, University of Naples "Federico II", Naples, Italy.

Wai Yan Yau (WY)

Department of Neuromuscular Disease, UCL Queen Square Institute of Neurology and The National Hospital for Neurology, London, UK.

Salvatore Rossi (S)

Department of Neuromuscular Disease, UCL Queen Square Institute of Neurology and The National Hospital for Neurology, London, UK.
Department of Neurology, Fondazione Policlinico Universitario A. Gemelli IRCSS, Rome, Italy; Institute of Neurology, Catholic University of the Sacred Heart, Rome, Italy.

Sarah J Beecroft (SJ)

Centre for Medical Research University of Western Australia, Harry Perkins Institute of Medical Research, QEII Medical Centre, Nedlands, Western Australia 6009, Australia.

Zane Jaunmuktane (Z)

Department of Clinical and Movement Neuroscience, UCL Queen Square Institute of Neurology and The National Hospital for Neurology, London, UK.

Zoe Dyer (Z)

Auckland District Health Board (ADHB), Auckland, New Zealand; Centre of Brain Research Neurogenetics Research Clinic, University of Auckland, New Zealand.

Gianina Ravenscroft (G)

Centre for Medical Research University of Western Australia, Harry Perkins Institute of Medical Research, QEII Medical Centre, Nedlands, Western Australia 6009, Australia.

Phillipa J Lamont (PJ)

Neurogenetic Unit, Royal Perth Hospital, Perth, West Australia, Australia.

Stuart Mossman (S)

Department of Neurology, Wellington Hospital, Wellington 6021, New Zealand.

Andrew Chancellor (A)

Department of Neurology, Tauranga Hospital, Private Bag, Cameron Road, Tauranga 3171, New Zealand.

Thierry Maisonobe (T)

Sorbonne Université, AP-HP, Hôpital Pitié-Salpêtrière, Department of Neurophysiology, Paris France.

Yann Pereon (Y)

CHU Nantes, Reference Centre for Neuromuscular Diseases, Hôtel-Dieu, Nantes, France.

Cecile Cauquil (C)

Department of Neurology, CHU Bicêtre, AP-HP, Le Kremlin-Bicêtre, France.

Silvia Colnaghi (S)

IRCCS Mondino Foundation, Pavia, Italy.

Giulia Mallucci (G)

IRCCS Mondino Foundation, Pavia, Italy.

Riccardo Curro (R)

Department of Brain and Behavioral Sciences, University of Pavia, Pavia, Italy.

Pedro J Tomaselli (PJ)

Department of Neurology, School of Medicine of Ribeirão Preto, University of São Paulo, Ribeirão Preto, Brazil.

Gilbert Thomas-Black (G)

Department of Clinical and Movement Neuroscience, UCL Queen Square Institute of Neurology and The National Hospital for Neurology, London, UK.

Roisin Sullivan (R)

Department of Neuromuscular Disease, UCL Queen Square Institute of Neurology and The National Hospital for Neurology, London, UK.

Stephanie Efthymiou (S)

Department of Neuromuscular Disease, UCL Queen Square Institute of Neurology and The National Hospital for Neurology, London, UK.

Alexander M Rossor (AM)

Department of Neuromuscular Disease, UCL Queen Square Institute of Neurology and The National Hospital for Neurology, London, UK.

Matilde Laurá (M)

Department of Neuromuscular Disease, UCL Queen Square Institute of Neurology and The National Hospital for Neurology, London, UK.

Menelaos Pipis (M)

Department of Neuromuscular Disease, UCL Queen Square Institute of Neurology and The National Hospital for Neurology, London, UK.

Alejandro Horga (A)

Department of Neuromuscular Disease, UCL Queen Square Institute of Neurology and The National Hospital for Neurology, London, UK.

James Polke (J)

Department of Neuromuscular Disease, UCL Queen Square Institute of Neurology and The National Hospital for Neurology, London, UK.

Diego Kaski (D)

Department of Clinical and Movement Neuroscience, UCL Queen Square Institute of Neurology and The National Hospital for Neurology, London, UK.

Rita Horvath (R)

Department of Clinical Neurosciences, University of Cambridge, Cambridge Biomedical Campus, Cambridge, UK.

Patrick F Chinnery (PF)

Department of Clinical Neurosciences, University of Cambridge, Cambridge Biomedical Campus, Cambridge, UK.
MRC Mitochondrial Biology Unit, University of Cambridge, Cambridge, UK.

Wilson Marques (W)

Department of Neurology, School of Medicine of Ribeirão Preto, University of São Paulo, Ribeirão Preto, Brazil.

Cristina Tassorelli (C)

Department of Brain and Behavioral Sciences, University of Pavia, Pavia, Italy.
IRCCS Mondino Foundation, Pavia, Italy.

Grazia Devigili (G)

UO Neurologia I, Fondazione IRCCS Istituto Neurologico "Carlo Besta", Milano, Italy.

Lea Leonardis (L)

Division of Neurology, Institute of Clinical Neurophysiology, University Medical Centre Ljubljana, Ljubljana, Slovenia.

Nick W Wood (NW)

Department of Neuromuscular Disease, UCL Queen Square Institute of Neurology and The National Hospital for Neurology, London, UK.

Adolfo Bronstein (A)

Department of Clinical and Movement Neuroscience, UCL Queen Square Institute of Neurology and The National Hospital for Neurology, London, UK.

Paola Giunti (P)

Department of Clinical and Movement Neuroscience, UCL Queen Square Institute of Neurology and The National Hospital for Neurology, London, UK.

Stephan Züchner (S)

Dr. John T. Macdonald Foundation Department of Human Genetics and John P. Hussman Institute for Human Genomics, University of Miami Miller School of Medicine, Miami, Florida, USA.

Tanya Stojkovic (T)

Sorbonne Université, AP-HP, Hôpital Pitié-Salpêtrière, Centre de Référence des Maladies Neuromusculaires, Nord/Est/Ile-de-France, Inserm UMR_S 974, Paris, France.

Nigel Laing (N)

Centre for Medical Research University of Western Australia, Harry Perkins Institute of Medical Research, QEII Medical Centre, Nedlands, Western Australia 6009, Australia.
Neurogenetics Unit, Department of Diagnostic Genomics, PathWest Laboratory Medicine, QEII Medical Centre, Nedlands, Australia.

Richard H Roxburgh (RH)

Auckland District Health Board (ADHB), Auckland, New Zealand; Centre of Brain Research Neurogenetics Research Clinic, University of Auckland, New Zealand.

Henry Houlden (H)

Department of Neuromuscular Disease, UCL Queen Square Institute of Neurology and The National Hospital for Neurology, London, UK.

Mary M Reilly (MM)

Department of Neuromuscular Disease, UCL Queen Square Institute of Neurology and The National Hospital for Neurology, London, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH